Back
EAPC Premium Access

Effect of secondary prevention: low density lipoprotein cholesterol and lipid-lowering drug use after first-ever myocardial infarction, by sex and age

Session: Poster Session III - Saturday 08:30 - 12:30 - Epidemiology/ Public health_Part 1
Topic: Epidemiology, lipids
Speaker: Doctor L. Hopstock (Tromso, NO)
Event: EuroPrevent 2017

Congress Presentation

Add to my library

Like

About the speaker

Doctor Laila Hopstock

UiT The Arctic University of Norway, Tromso (Norway)
0 follower

15 more presentations in this session

Epidemiology/ Public health_Part 1 - Poster discussant:.

Access
Like
Thumbnail

Changes in body weight and composition are associated with changes in left ventricular and atrial geometry in the general population

Access
Like
Thumbnail

Differences in measured and self-reported anthropometric data: the Italian Osservatorio Epidemiologico Cardiovascolare/Health Examination Survey 2008-2012

Speaker: Doctor L. Palmieri (Rome, IT)

Access
Abstract
Like
Thumbnail

Clinical implications of low-to-intermediate trials for primary prevention of atherosclerotic CVD and risk stratification with N-terminal pro-B-type natriuretic peptide in the Rotterdam Study

Speaker: Ms J. Pavlovic (Rotterdam, NL)

Access
Abstract
Like
Thumbnail

Leisure time physical activity initiated by employer and its health effects. A 15-month follow-up study

Speaker: Doctor M. Skogstad (Oslo, NO)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session III - Saturday 08:30 - 12:30 - Epidemiology/ Public health_Part 1

Speakers: Doctor L. Hopstock, Doctor L. Palmieri, Ms J. Pavlovic, Doctor M. Skogstad
Access
Like
Thumbnail

About the event

Image

EuroPrevent 2017

6 April - 8 April 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources